Yesterday, General Director Sayabek Sakhiyev and Deputy General Director for Production Yevgeniy Yermakov visited the Nuclear Medicine Center “MedInvestGroup Kazakhstan” LLP in Shymkent.
This center carries out early diagnosis of cancer using the radiopharmaceutical "Fluorodeoxyglucose F-18", which is produced at the Institute of Nuclear Physics.
At the meeting with the leadership of the Center, the issues of further development of cooperation were discussed, in particular increasing the production of radiopharmaceuticals and the issue of air supplies of radiopharmaceuticals.
